Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097-6110.
Alvarado-Miranda A, Lara-Medina FU, Muñoz-Montaño WR, Zinser-Sierra JW, Galeana PAC, Garza CV, Sanchez Benitez D, Limón Rodríguez JA, Arce Salinas CH, Guijosa A, Arrieta O. Alvarado-Miranda A, et al. Among authors: arce salinas ch. Curr Oncol. 2024 Nov 15;31(11):7177-7179. doi: 10.3390/curroncol31110529. Curr Oncol. 2024. PMID: 39590178 Free PMC article.
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer.
Alvarado-Miranda A, Lara-Medina FU, Muñoz-Montaño WR, Zinser-Sierra JW, Galeana PAC, Garza CV, Sanchez Benitez D, Limón Rodríguez JA, Arce Salinas CH, Guijosa A, Arrieta O. Alvarado-Miranda A, et al. Among authors: arce salinas ch. Curr Oncol. 2023 Jun 24;30(7):6097-6110. doi: 10.3390/curroncol30070454. Curr Oncol. 2023. PMID: 37504314 Free PMC article.
Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy.
Villarreal-Garza C, Bargallo-Rocha JE, Soto-Perez-de-Celis E, Lasa-Gonsebatt F, Arce-Salinas C, Lara-Medina F, Reynoso-Noverón N, Matus-Santos J, Cabrera P, Alvarado-Miranda A, Mohar A. Villarreal-Garza C, et al. Breast Cancer Res Treat. 2016 Jun;157(2):385-394. doi: 10.1007/s10549-016-3811-2. Epub 2016 May 17. Breast Cancer Res Treat. 2016. PMID: 27189008
Clinical and Epidemiological Profile of Breast Cancer in Mexico: Results of the Seguro Popular.
Reynoso-Noverón N, Villarreal-Garza C, Soto-Perez-de-Celis E, Arce-Salinas C, Matus-Santos J, Ramírez-Ugalde MT, Alvarado-Miranda A, Cabrera-Galeana P, Meneses-García A, Lara-Medina F, Bargalló-Rocha E, Mohar A. Reynoso-Noverón N, et al. J Glob Oncol. 2017 Dec;3(6):757-764. doi: 10.1200/JGO.2016.007377. Epub 2017 Feb 8. J Glob Oncol. 2017. PMID: 29244990 Free PMC article.
Clinical characteristics and outcomes of older women with breast cancer in Mexico.
Cabrera-Galeana P, Soto-Perez-de-Celis E, Reynoso-Noverón N, Villarreal-Garza C, Arce-Salinas C, Matus-Santos J, Ramírez-Ugalde MT, Alvarado-Miranda A, Meneses-García A, Lara-Medina F, Torres-Dominguez J, Bargalló-Rocha E, Mohar A. Cabrera-Galeana P, et al. J Geriatr Oncol. 2018 Nov;9(6):620-625. doi: 10.1016/j.jgo.2018.04.003. J Geriatr Oncol. 2018. PMID: 29691196
Outcomes of Hispanic women with lymph-node positive, HER2 positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab in Mexico.
Villarreal-Garza C, Soto-Perez-de-Celis E, Sifuentes E, Ruano S, Baez-Revueltas B, Lara-Medina F, Arce-Salinas C, Alvarado-Miranda A, Chavarri-Guerra Y, Caro-Sanchez C, Castañeda-Soto N, Bargallo-Rocha E, Mohar A. Villarreal-Garza C, et al. Breast. 2015 Jun;24(3):218-23. doi: 10.1016/j.breast.2015.01.011. Epub 2015 Feb 16. Breast. 2015. PMID: 25698148
Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer.
Villarreal-Garza C, Mohar A, Bargallo-Rocha JE, Lasa-Gonsebatt F, Reynoso-Noverón N, Matus-Santos J, Cabrera P, Arce-Salinas C, Lara-Medina F, Alvarado-Miranda A, Ramírez-Ugalde MT, Soto-Perez-de-Celis E. Villarreal-Garza C, et al. Clin Breast Cancer. 2017 Jun;17(3):e95-e102. doi: 10.1016/j.clbc.2016.11.007. Epub 2016 Nov 23. Clin Breast Cancer. 2017. PMID: 28065398
[Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico].
Arce-Salinas C, Lara-Medina FU, Alvarado-Miranda A, Castañeda-Soto N, Bargalló-Rocha E, Ramírez-Ugalde MT, Pérez-Sánchez V, Rivera L, Gambo-Vignole C, Santamaría-Galicia J, Nieves-Casas RI, Morán-Muñoz H, Mohar-Betancourt A. Arce-Salinas C, et al. Rev Invest Clin. 2012 Jan-Feb;64(1):9-16. Rev Invest Clin. 2012. PMID: 22690524 Spanish.
21 results